MARKET

BSTG

BSTG

Biostage
OTCMQB
6.00
0.00
0.00%
Closed 13:47 03/21 EDT
OPEN
5.99
PREV CLOSE
6.00
HIGH
6.24
LOW
5.99
VOLUME
1.88K
TURNOVER
11.43K
52 WEEK HIGH
9.00
52 WEEK LOW
1.010
MARKET CAP
69.86M
P/E (TTM)
-6.4096
1D
5D
1M
3M
1Y
5Y
Regenerative medicine developer Biostage cancels Nasdaq uplisting, public offering
Seeking Alpha · 02/03 22:57
BRIEF-Biostage Amends CEO Employment Agreement
Reuters · 01/12 13:39
Insider Sell: Biostage
Insider Sell: Biostage
MT Newswires · 12/09/2022 17:35
Biostage GAAP EPS of -$0.10
Seekingalpha · 11/14/2022 21:37
Biostage Reports Corporate Highlights and Third Quarter Financial Results
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted at the Mayo Clinic and published August of 2021) and FDA approval to commenc...
PR Newswire · 11/14/2022 21:22
Biostage Schedules Conference Call and Webcast for Q3 2022 Results
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in treating esophageal cancer (conducted at the Mayo Clinic and published last August) and FDA approval to commence...
PR Newswire · 11/10/2022 15:21
Regenerative therapy developer Biostage files for Nasdaq uplisting, $6M offering
Seekingalpha · 10/28/2022 22:10
BRIEF-Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Reuters · 10/27/2022 21:49
More
About BSTG
Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe technology. Its Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient's own cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, trachea or bronchus that are caused due to cancer, infection, trauma or congenital abnormalities. Its Cellframe technology is engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. Its Cellframe technology platform is used to create organ specific Cellspan implants. Its product candidates are in development and have not yet received regulatory approval for sale anywhere in the world.

Webull offers kinds of Biostage Inc stock information, including OTCMQB:BSTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSTG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BSTG stock methods without spending real money on the virtual paper trading platform.